Wáczek Frigyes

Title: The Innovative Mind of Wáczek Frigyes

Introduction

Wáczek Frigyes is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve vital roles in cancer treatment.

Latest Patents

Frigyes holds a patent for his invention titled "3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors." This invention revolves around compounds such as N-{4-[1-(2,6-dichloro-4-sulfamoyl-phenyl)-3-dimethylamino-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-ylmethyl]-phenyl}-2-diethylamino-acetamide. These compounds are especially useful as cyclin dependent kinase (CDK) inhibitors, which play a crucial role in the prophylaxis and treatment of cancer and other proliferative diseases. The patent also details processes for synthesizing these innovative compounds and their related intermediates.

Career Highlights

Throughout his career, Frigyes has been associated with prominent institutions such as the Medical University of Innsbruck and Vichem Chemie Kutató Korlátolt Felelősségű Társaság. His work in these organizations has paved the way for important discoveries in the field of pharmaceuticals.

Collaborations

Frigyes has collaborated with esteemed colleagues in his field, including Winfried Wunderlech and Lukas A Huber. These partnerships have further enriched his research and contributed to the advancements in medicinal applications of his inventions.

Conclusion

Wáczek Frigyes exemplifies a dedicated inventor whose work in creating cyclin dependent kinase inhibitors promises significant advancements in cancer treatment. His patent serves as a testament to his innovative prowess and commitment to improving human health through science.